CIP
AUPH icon

Cornerstone Investment Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History

Cornerstone Investment Partners’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Sell
13,831
-666
-5% -$10.6K 0.01% 258
2026
Q1 		$215K Buy
14,497
+3,326
+30% +$48.6K 0.01% 255
2025
Q4 		$178K Buy
+11,171
New +$158K 0.01% 189

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cornerstone Investment Partners's AUPH Position: Q2 2026 in Review

Cornerstone Investment Partners reduced its Aurinia Pharmaceuticals (AUPH) stake by 4.6% in Q2 2026, selling an estimated $10.6K and leaving 13,831 shares worth $235K. The position accounts for 0.01% of the portfolio, ranked #258.

Cornerstone Investment Partners first reported a position in AUPH in Q4 2025 and has held it in 3 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Cornerstone Investment Partners held 13,831 shares of Aurinia Pharmaceuticals worth $235K as of Q2 2026.
  • Cornerstone Investment Partners sold 666 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $10.6K.
  • Aurinia Pharmaceuticals made up 0.01% of Cornerstone Investment Partners's portfolio in Q2 2026, its #258 holding.
  • Cornerstone Investment Partners first reported a position in Aurinia Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Cornerstone Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.